Main > OBESITY. (**) > USA. R. Treat.>MC4R Agonist Inj.



USA. R. Treat.>MC4R Agonist Inj.'s subsections
(*) EU CE Mark Date: 2021. 07.23
(*) UK Approval Date: 2021. 09.21
(*) USA Approval Date: 2020. 11.27.
(*) USA Launch Date: 2021. 06.24.
Company
Company DIST. USA
Generic Name: Setmelanotide
MC4R: MelanoCortin-4-Receptor
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 7
Patent>UpDate: 2021. 11.23
Product Web-Site

USA. R. Treat.>MC4R Agonist Inj.'s products
This section has no products